Search Results - "Dellamonica, P"

Refine Results
  1. 1
  2. 2

    Dengue fever: clinical features by Dellamonica, P

    “…The vector for dengue fever and chikungunya, Aedes albopictus, was recently identified in Southeastern France, although the usual vector for dengue fever is…”
    Get full text
    Journal Article
  3. 3

    Drug-resistance genotyping in HIV-1 therapy : the VIRADAPT randomised controlled trial by DURANT, J, CLEVENBERGH, P, HALFON, P, DELGIUDICE, P, PORSIN, S, SIMONET, P, MONTAGNE, N, BOUCHER, C. A. B, SCHAPIRO, J. M, DELLAMONICA, P

    Published in The Lancet (British edition) (26-06-1999)
    “…Growing evidence has linked HIV-1 resistance mutations and drug failure. The use of genotypic-resistance analysis to assist therapeutic decision-making in…”
    Get full text
    Journal Article
  4. 4

    A large French prospective cohort of HIV‐infected patients: the Nadis Cohort by Pugliese, P, Cuzin, L, Cabié, A, Poizot‐Martin, I, Allavena, C, Duvivier, C, El Guedj, M, De La Tribonnière, X, Valantin, MA, Dellamonica, P

    Published in HIV medicine (01-09-2009)
    “…Objectives The aim of this article is to describe the development of a dynamic French cohort of HIV‐infected patients, the methodological issues and decisions…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Can boosted atazanavir induce hyperlipotrophy? by Dellamonica, P.

    Published in The Journal of infection (01-06-2006)
    “…Individual variations in glucuronation may result in differences in serum concentrations of atazanavir, resulting in lipodystrophy, illustrating the difficulty…”
    Get full text
    Journal Article
  7. 7

    Antibiotic misuse : a prospective clinical audit in a French university hospital by PULCINI, C, CUA, E, LIEUTIER, F, LANDRAUD, L, DELLAMONICA, P, ROGER, P. M

    “…The aim of the study presented here was to prospectively audit antibiotic prescriptions given to patients attending L'Archet Hospital in Nice, France, with…”
    Get full text
    Journal Article
  8. 8

    Effect of Tipranavir/Ritonavir Combination on the Pharmacokinetics of Tadalafil in Healthy Volunteers by Garraffo, R., Lavrut, T., Ferrando, S., Durant, J., Rouyrre, N., MacGregor, T. R., Sabo, J. P., Dellamonica, P.

    Published in Journal of clinical pharmacology (01-07-2011)
    “…This study evaluated the effects of single‐dose administration and steady‐state concentrations of tipranavir 500 mg and ritonavir 200 mg (TPV/r) combination on…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy : pharmacological data from the Viradapt Study by DURANT, J, CLEVENBERGH, P, GARRAFFO, R, HALFON, P, ICARD, S, DEL GIUDICE, P, MONTAGNE, N, SCHAPIRO, J. M, DELLAMONICA, P

    Published in AIDS (London) (07-07-2000)
    “…In a prospective randomized study, the impact of plasma protease inhibitor (PI) trough levels on changes in HIV RNA were assessed in patients treated with…”
    Get full text
    Journal Article
  11. 11

    Characteristics and consequences of medical care interruptions in HIV-infected patients in France by CUZIN, L., DELLAMONICA, P., YAZDANPANAH, Y., BOUCHEZ, S., REY, D., HOEN, B., CABIÉ, A.

    Published in Epidemiology and infection (01-08-2016)
    “…To describe the consequences of medical care interruptions (MCIs) we selected patients with at least two medical encounters between January 2006 and June 2013…”
    Get full text
    Journal Article
  12. 12

    Long‐term (96‐week) follow‐up of antiretroviral‐naïve HIV‐infected patients treated with first‐line lopinavir/ritonavir monotherapy in the MONARK trial by Ghosn, J, Flandre, P, Cohen‐Codar, I, Girard, P‐M, Chaix, M‐L, Raffi, F, Dellamonica, P, NgoVan, P, Norton, M, Delfraissy, J‐F

    Published in HIV medicine (01-02-2010)
    “…Background The toxicities, cost and complexity of triple combinations warrant the search for other treatment options, such as boosted protease inhibitor (PI)…”
    Get full text
    Journal Article
  13. 13

    Adverse effects of parenteral antimicrobial therapy for chronic bone infections by Pulcini, C., Couadau, T., Bernard, E., Lorthat-Jacob, A., Bauer, T., Cua, E., Mondain, V., Chichmanian, R.-M., Dellamonica, P., Roger, P.-M.

    “…Responsible pathogens of chronic bone infections (CBI) are frequently resistant, requiring parenteral antimicrobial therapy. Therefore, adverse effects may be…”
    Get full text
    Journal Article
  14. 14

    Six weeks antibiotic therapy for all bone infections: results of a cohort study by Farhad, R, Roger, P.-M, Albert, C, Pélligri, C, Touati, C, Dellamonica, P, Trojani, C, Boileau, P

    “…There is no consensus on the antibiotic therapy for bone infection due to the heterogeneous spectrum of diseases. Most authors suggest different durations of…”
    Get full text
    Journal Article
  15. 15

    Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial by Bentz, L., Enel, P., Dunais, B., Durant, J., Poizot-Martin, I., Tourette-Turgis, C., Rébillon, M., Le Duff, F., Dellamonica, P., Pradier, C.

    Published in AIDS care (01-12-2010)
    “…Objective. Post-exposure prophylaxis (PEP) is recommended for the management of sexual HIV-risk exposure. However, a high percentage of exposed patients…”
    Get full text
    Journal Article
  16. 16

    Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription by Colombie, V, Pugliese-Wehrlen, S, Deuffic-Burban, S, Cuzin, L, Pugliese, P, Katlama, C, Poizot-Martin, I, Raffi, F, Cabie, A, Dellamonica, P, Yazdanpanah, Y

    Published in International journal of STD & AIDS (01-12-2012)
    “…To estimate the cost of the first combination antiretroviral drug therapy (cART) in HIV-infected patients and to determine factors associated with expensive…”
    Get more information
    Journal Article
  17. 17

    La dengue : aspects cliniques by Dellamonica, P.

    Published in Archives de pédiatrie (Paris) (2009)
    “…La circulation récente d’ Aedes albopictus, vecteur potentiel de la dengue et du chikungunya dans le Sud-Est de la France, alors que le vecteur classique de la…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Botulism and hot-smoked whitefish: a family cluster of type E botulism in France, September 2009 by King, L A, Niskanen, T, Junnikkala, M, Moilanen, E, Lindstrom, M, Korkeala, H, Korhonen, T, Popoff, M, Mazuet, C, Callon, H, Pihier, N, Peloux, F, Ichai, C, Quintard, H, Dellamonica, P, Cua, E, Lasfargue, M, Pierre, F, de Valk, H

    “…A family cluster of three cases of type E botulism were identified in south-east France in September 2009. The suspected food source of infection was a vacuum…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Impact of Highly Active Antiretroviral Therapy on the Incidence of Visceral Leishmaniasis in a French Cohort of Patients Infected with Human Immunodeficiency Virus by del Giudice, P., Mary-Krause, M., Pradier, C., Grabar, S., Dellamonica, P., Marty, P., Gastaut, J. A., Costagliola, D.

    Published in The Journal of infectious diseases (01-11-2002)
    “…The incidence of human immunodeficiency virus (HIV)–Leishmania coinfections in France was estimated on the basis of the French Hospital Database on HIV, and…”
    Get full text
    Journal Article